| Geld/Brief | 9,32 $ / 20,00 $ |
| Spread | +114,59% |
| Schluss Vortag | 13,52 $ |
| Gehandelte Stücke | 25.165 |
| Tagesvolumen Vortag | 257.095,2 $ |
| Tagestief 12,55 $ Tageshoch 13,63 $ | |
| 52W-Tief - 52W-Hoch 13,18 $ | |
| Jahrestief - Jahreshoch 13,18 $ | |
| Umsatz in Mio. | - |
| Operatives Ergebnis (EBIT) in Mio. | -59,28 $ |
| Jahresüberschuss in Mio. | -60,08 $ |
| Umsatz je Aktie | - |
| Gewinn je Aktie | -1,23 $ |
| Gewinnrendite | - |
| Umsatzrendite | - |
| Return on Investment | -39,09% |
| Marktkapitalisierung in Mio. | 622,99 $ |
| KGV (Kurs/Gewinn) | - |
| KBV (Kurs/Buchwert) | - |
| KUV (Kurs/Umsatz) | - |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +85,16% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Düsseldorf | 11,10 € | -3,48% | 11,50 € | 07.07.26 | |
| NYSE | 12,76 $ | -6,04% | 13,58 $ | 02.07.26 | |
| Nasdaq | 13,18 $ | -2,51% | 13,52 $ | 07.07.26 | |
| AMEX | 13,52 $ | - | - | 25.06.26 | |
| Tradegate | 12,10 € | +1,68% | 11,90 € | 07.07.26 | |
| Quotrix | 11,90 € | +7,21% | 11,10 € | 07.07.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 06.07.26 | 13,52 | 257 T |
| 02.07.26 | 12,65 | 45.793 |
| 01.07.26 | 11,87 | 1,62 M |
| 30.06.26 | 12,98 | 482 T |
| 29.06.26 | 17,82 | 470 T |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 12,98 $ | +4,16% |
| 1 Monat | 9,92 $ | +36,29% |
| 6 Monate | - | - |
| 1 Jahr | - | - |
| 5 Jahre | - | - |
| Marktkapitalisierung | 622,99 Mio. $ |
| Streubesitz | 33,33% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +10,44% | EQT Fund Management S.à r.l. |
| +5,65% | Sanofi |
| +5,01% | Cormorant Asset Management, LLC |
| +4,17% | TCG Crossover Management, LLC |
| +3,29% | Federated Hermes Inc |
| +3,15% | Casdin Capital, LLC |
| +3,12% | Andera Partners |
| +2,96% | FMR Inc |
| +2,44% | Nantahala Capital Management, LLC |
| +1,99% | Federated Hermes Kaufmann Growth |
| +1,99% | Federated Hermes Kaufmann R |
| +1,44% | Aberdeen Group PLC |
| +1,36% | Fidelity Growth Compy Commingled Pl S |
| +1,25% | Federated Hermes Kaufmann Small Cap A |
| +1,25% | Federated Hermes Kaufmann Small Cap Grow |
| +1,22% | Perceptive Advisors LLC |
| +1,22% | Samsara BioCapital, LLC |
| +1,03% | Fidelity Growth Company Fund |
| +0,84% | Siren, L.L.C. |
| +0,71% | abrdn Healthcare Investors |
| +0,62% | abrdn World Healthcare |
| +0,61% | LMR Partners LLP |
| +0,41% | SEVEN GRAND MANAGERS, LLC |
| +0,35% | abrdn Life Sciences Investors |
| +0,32% | Redmile Group, LLC |
| +0,29% | Fidelity Growth Company K6 |
| +0,26% | Fidelity Series Growth Company |
| +0,19% | Millennium Management LLC |
| +0,15% | Alyeska Investment Group, L.P. |
| +0,15% | Pfizer Inc |
| +0,10% | LAURION CAPITAL MANAGEMENT LP |
| +0,08% | Protea Sectoral Hlthcare Opps P USD Acc |
| +0,04% | Federated Hermes Kaufmann II P |
| +0,03% | Protea Sectoral Biotech Opps IF USD Acc |
| +0,02% | Fidelity Select Pharmaceuticals Port |
| +0,02% | Fidelity Nasdaq Composite Index |
| 0,00% | Bellevue Diversified Healthcare U2 CHF |
| +48,35% | Institutionelle Aktionäre |
| +33,33% | Streubesitz |
| -15,02% | Individuelle Aktionäre |
